NCT01982266终止不适用
A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 2
- 主要终点
- Adverse events
研究概览
简要总结
This is a prospective, multicenter, single arm feasibility study of the safety and performance of the GRADION™ Hip Total Cartilage Replacement (TCR)™ in patients who require cartilage replacement.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary hip surgery for Noninflammatory Degenerative Joint Disease (NIDJD) such as osteo/degenerative arthritis, and is indicated for cartilage replacement
- •Skeletally mature or at least 18 years of age and has normal anatomy
- •Patient signs the Informed Consent form
- •Failed medical management
- •There will be size limitations on patients also - available size range is 46mm-54mm.
排除标准
- •Allergic to polyether urethane, sodium polyacrylate, bone cement or any of its components
- •Previous fusion, acute femoral neck fracture and/or above knee amputation
- •Revision of any previous hip procedure
- •Slipped capital femoral epiphysis (SCFE)
- •Rheumatoid arthritis
结局指标
主要结局
Adverse events
时间窗: 6 months
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL SystemPeripheral Arterial DiseaseNCT05058456Shockwave Medical, Inc.35
已完成
不适用
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)Heavy Menstrual BleedingNCT06634719Rejoni Inc.13
终止
不适用
DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic StrokeAcute Ischemic StrokeNCT05139147MIVI Neuroscience, Inc.16
终止
不适用
The Pristine Post-Market StudyHemodialysis ComplicationHemodialysis Catheter InfectionHemodialysis Access FailureCentral Venous Catheter Related Bloodstream InfectionEnd Stage Renal DiseaseKidney Failure, ChronicNCT05228132C. R. Bard142
Unknown
不适用
The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance CriteriaCoronary Artery DiseaseNCT04617899CardioNavi MedTech (Wuhan) Co., Ltd.120
